急性心肌梗死延迟冠状动脉介入治疗的远期疗效Clinical assessment for the long-term benefits of delayed percutaneous transluminal coronary intervention in patients with acute myocardial infarction
罗心平,施海明,洪鸣,朱军,倪唤春,李剑,山缨,王彩萍,李勇,范维琥
摘要(Abstract):
目的观察延迟冠状动脉(冠脉)介入治疗(PCI)对急性心肌梗死患者远期疗效的影响。方法回顾性分析1996年1月至2002年10月我院276例急性心肌梗死患者的临床资料,根据患者是否接受介入治疗或接受介入治疗的种类、将患者分为直接急诊PCI治疗组(急诊组)75例,延迟PCI治疗组(延迟组)73例以及常规药物治疗组(对照组)128例。收集并分析住院期间的临床资料,对存活出院的患者随访,记录主要心血管事件(MACE)的发生情况,并于出院第12~48个月进行超声心动图检查。结果基线资料急诊组ST段抬高例数高于其他两组,住院天数明显降低(P<0.05)。住院期间病死率对照组明显高于急诊组和延迟组。平均随访4.3±2.7年(1.8~7.5年),完成随访247人(89.5%)。随访期左心室射血分数(LVEF)值延迟组为57.4%±3.4%,急诊组为59.3%±7.5%,对照组为54.7%±4.1%。延迟组死亡1例,急诊组死亡1例,对照组死亡14例。与对照组相比,延迟PCI治疗可改善心肌梗死患者的左心室功能,降低远期MACE的发生率;与急诊组相比,其左心室功能改善及远期临床事件发生率的降低差异无统计学意义。结论与常规药物治疗相比,延迟PCI治疗可改善急性心肌梗死患者的远期预后。
关键词(KeyWords): 心肌梗死;血管成形术,经腔,经皮冠状动脉;预后
基金项目(Foundation):
作者(Author): 罗心平,施海明,洪鸣,朱军,倪唤春,李剑,山缨,王彩萍,李勇,范维琥
参考文献(References):
- [1]Antman EM,Anbe DT,Armstrong DW,et al.ACC/AHA guidelinesfor the management of patients with ST-elevation myocardial infarc-tion:a report of the american college of cardiology/american heart as-sociation task force on practice guidelines(committee to revise the1999 guidelines for the management of patients with acute myocardialinfarction).Circulation,2004,110:588-636.
- [2]Steg PG,Bonnefoy E,Chabaud S,et al.Impact of time to treatmenton mortality after prehospital fibrinolysis or primary angioplasty:datafrom the CAPTIM randomized clinical trial.Circulation,2003,108:2851-2856.
- [3]Keeley E,Boura JA,Grines CL.Primary angioplasty versus intrave-nous thrombolytic therapy for acute myocardial infarction:a quantita-tive review of 23 randomised trials.Lancet,2003,361:14-20.
- [4]Magid DJ,Calonge BN,Rumsfeld JS,et al,for the National Regis-try of Myocardial Infarction 2 and 3 Investigators.Relation betweenhospital primary angioplasty volume and mortality for patients withacute MI treated with primary angioplasty vs thrombolytic therapy.JAMA,2000,284:3131-3138.
- [5]Avraham C,Shamuel G,Solomon B,et al.Delayed percutaneoustransluminal coronary angioplasty after acute myocardial infarction.Int J Cardio,1998,63:199-204.
- [6]Hajime H,Masayuki T,Kazuo M,et al.Long-time beneficial effectof late reperfusion for acute anterior myocardial infarction with percu-taneous transluminal coronary angioplasty.Circulation,1998,98:2377-2382.
- [7]刘宗军,金惠根,尚孝堂,等.急性心肌梗死后延迟PTCA及支架植入对慢性期左室重构和心脏事件的影响.介入放射学杂志,2002,2:82-84.
- [8]Alhaddad IA,Kloner RA,Hakim I,et al.Benefits of late coronary ar-tery reperfusion on infarct expansion progressively diminish overtime:relation to viable islets of myocytes within the scar.Am Heart J,1996,131:451-457.
- [9]Ross AM,Coyne KS,Reiner JS,et al.For the PACT investigators.A randomized trial comparing primary angioplasty with a strategy ofshort-acting thrombolysis and immediate planned rescue angioplasty inacute myocardial infarction:the PACT trial.J Am Coll Cardiol,1999,34:1954-1962.
- [10]Tiefenbrunn AJ,Nisha C,French WJ,et al.Clinical experiencewith primary percutaneous transluminal coronary angioplasty comparedwith alteplase(recombinant tissue-type plasminogen activator)in pa-tients with acute myocardial infarction:a report from the second na-tional registry of myocardial infarction(NRMI-2).J Am Coll Cardi-ol,1998,31:1240-1245.